Regulation of mast cell activation by complement-derived peptides
Related Experiment Video
Updated: Aug 24, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Anna Erdei1, Márton Andrásfalvy, Hajna Péterfy
1Department of Immunology, Research Group of the Hungarian Academy of Sciences, Eötvös Loránd University, Pázmány Péter s. 1/C, H-1117 Budapest, Hungary. anna.erdei@freemail.hu
Abstract:
It is known for more than 25 years that the complement-derived anaphylatoxic peptides, C3a, C4a and C5a are potent activators of basophils and certain types of mast cells. Although tissue distribution of receptors for C3a and C5a well exceeds myeloid cells, apparently they are not expressed on mucosal type mast cells, consequently these cells are not activated by C3a and C5a. Our results do however demonstrate that C3a and peptides related to this complement activation product are able to inhibit FcRI-clustering induced activation of mucosal type mast cells-such as RBL-2H3 cells and bone-marrow derived mast cells. Based on the current results we propose the presence of separate "activator" and "inhibitor" sequence motifs in C3a which are in balance under physiologic conditions.
Related Concept Videos
Complement System
Differentiation of Common Myeloid Progenitor Cells
Inflammation
Role of Matrix Metalloproteases in Degradation of ECM
A...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

